HK2 and neoplasm: Some inhibitors of HK2, such as 2-deoxyglucose and 3-bromopyruvate, can inhibit glycolysis of a variety of tumor cells and exhibit anticancer effects [36], suggesting that HK2 may be an effective anticancer target.